Navigation Links
ITRA Global Report Makes the Case That Bio Tech Companies Should Consider Tucson, Arizona for Relocation or Expansion
Date:11/27/2013

Tucson, Arizona (PRWEB) November 27, 2013

Tucson, Arizona should be on any bioscience or biotechnology company’s short list for relocation or expansion, according to a white paper issued by ITRA Global affiliate Commercial Real Estate Group of Tucson LLC.

The nine-page report, “The Bio Industry in Tucson, Arizona,” points out that several bioscience companies already thrive in the region, including Ventana Medical Systems, Sanofi and SynCardia Systems. It also mentions that Accelerate Diagnostics moved from Denver to Tucson in 2012.

“I was impressed from my first contacts with Pima County, the Tucson mayor’s office, the state of Arizona and the Tucson Regional Economic Opportunities Office,” Accelerate President and CEO, Lawrence Mehren, is quoted as saying in the white paper. “We could tell this was a place that valued our businesses and wanted to help.”

“Proximity to large private enterprises in bioscience is only one of the reasons Tucson is a rising biotechnology star,” says Michael Coretz, principal of Commercial Real Estate Group of Tucson / ITRA Global. “Our city also boasts available venture capital, an encouraging spirit of entrepreneurship and a strong research community, including the University of Arizona’s Bio5 Institute.”

The availability of federal and state government funding and a highly skilled workforce are other reasons Tucson, the hub of Southern Arizona, should get prime consideration by biotechnology and bioscience firms, the report says.

Commercial Real Estate of Tucson is the Tucson Affiliate of ITRA Global and Michael Coretz is a site selection expert with indepth knowledge of biotech companies for local, regional and national clients. Specialized real estate needs for this industry are addressed in the white paper, which is available on the CREG of Tucson website.

ITRA Global is an organization of commercial real estate firms specializing in the representation of tenants and buyers of office, industrial, and retail facilities. It is one of the largest commercial real estate organizations devoted to representing corporate tenants and buyers. With coverage in major markets around the world, ITRA Global consists of seasoned professionals with an average of twenty years’ experience and is differentiated by its focus on advocacy for the corporate tenant and buyer. Clients benefit by having an experienced professional as their trusted advisor -- conflict-free representation with total objectivity.

For more information about the white paper, contact Michael Coretz by telephone at +1.520.299.3400 or by email, michael(at)cretucson.com. For more information about ITRA Global, you may contact the Executive Director of the organization, Beth Wade at +1.706.654.3201.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11374985.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply ... a time. So which eye do you rinse first if a dangerous substance enters both ... Duo Eye Wash with its unique dual eye piece. , “Whether its dirt and ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):